CoChat

Type 2 deiodinase at the crossroads of thyroid hormone action

Open access
Arrojo e Drigo, Rafael, Bianco, Antonio C. · 2011 · The International Journal of Biochemistry & Cell Biology
Cited by 93

The DOI matches its Crossref record; 28 of the 28 references it cites were found in a registry or an index.

Abstract

Thyroid hormone action can be customiZed on a cell-specific fashion through the controlled action of the deiodinase group of enzymes, which are homodimeric thioredoxin fold containing selenoproteins. Whereas the type II deiodinase (D2) initiates thyroid hormone signaling by activating the pro-hormone thyroxine (T4) to the biologically active T3 molecule, the type III deiodinase (D3) terminates thyroid hormone action by catalyzing the inactivation of both T4 and T3 molecules. Deiodinases play a role in thyroid hormone homeostasis, development, growth and metabolic control by affecting the intracellular levels of T3 and thus gene expression on a cell-specific basis. Whereas both Dio2 and Dio3 are transcriptionally regulated, ubiquitination of D2 is a switch mechanism that controls D2 activity and intracellular T3 production. The hedgehog-inducible WSB-1 and the yeast Doa10 mammalian ortholog TEB4 are two E3 ligases that inactivate D2 via ubiquitination. Inactivation involves disruption of the D2:D2 dimer and can be reversed via two ubiquitin-specific proteases, USP20 and USP33, rescuing catalytic activity and T3 production. The ubiquitin-based switch mechanism that controls D2 activity illustrates how different cell types fine-tune thyroid hormone signaling, making D2 a suitable target for pharmacological intervention. This article reviews the cellular and molecular aspects of D2 regulation and the current models of D2-mediated thyroid hormone signaling.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.biocel.2011.05.016

Cites

28 of 28 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 28 references

Research works printed but not linked: 85

  1. Allen, 2007, The solution structure of the ZnF UBP domain of USP33/VDU1, Protein Sci, 16, 2072, 10.1110/ps.072967807 · DOI
  2. Arai, 2006, Structure of human ubiquitin-conjugating enzyme E2 G2 (UBE2G2/UBC7), Acta Crystallogr Sect F Struct Biol Cryst Commun, 62, 330, 10.1107/S1744309106009006 · DOI
  3. Archange, 2008, The WSB1 gene is involved in pancreatic cancer progression, PLoS One, 3, e2475, 10.1371/journal.pone.0002475 · DOI · Paper page
  4. Baqui, 2003, Human type 3 iodothyronine selenodeiodinase is located in the plasma membrane and undergoes rapid internalization to endosomes, J Biol Chem, 278, 1206, 10.1074/jbc.M210266200 · DOI · Paper page
  5. Baqui, 2000, Distinct subcellular localization of transiently expressed types 1 and 2 iodothyronine deiodinases as determined by immunofluorescence confocal microscopy, Endocrinology, 141, 4309, 10.1210/endo.141.11.7872 · doi:10.1210/endo.141.11.7872 · Paper page
  6. Bassett, 2010, Optimal bone strength and mineralization requires the type 2 iodothyronine deiodinase in osteoblasts, Proc Natl Acad Sci U S A, 107, 7604, 10.1073/pnas.0911346107 · DOI · Paper page
  7. Baur, 2006, Therapeutic potential of resveratrol: the in vivo evidence, Nat Rev Drug Discov, 5, 493, 10.1038/nrd2060 · DOI · Paper page
  8. Bazirgan, 2008, Cue1p is an activator of Ubc7p E2 activity in vitro and in vivo, J Biol Chem, 283, 12797, 10.1074/jbc.M801122200 · DOI
  9. Berry, 1991, Type I iodothyronine deiodinase is a selenocysteine-containing enzyme, Nature, 349, 438, 10.1038/349438a0 · DOI · Paper page
  10. Bianco, 1992, Adenosine 3′,5′-monophosphate and thyroid hormone control of uncoupling protein messenger ribonucleic acid in freshly dispersed brown adipocytes, Endocrinology, 130, 2625, 10.1210/endo.130.5.1374009 · doi:10.1210/endo.130.5.1374009 · Paper page
  11. Botero, 2002, Ubc6p and ubc7p are required for normal and substrate-induced endoplasmic reticulum-associated degradation of the human selenoprotein type 2 iodothyronine monodeiodinase, Mol Endocrinol, 16, 1999, 10.1210/me.2002-0135 · DOI · Paper page
  12. Briggman, 2005, NMR assignment of human ubiquitin conjugating enzyme Ubc7, J Biomol NMR, 32, 340, 10.1007/s10858-005-1257-7 · DOI
  13. Callebaut, 2003, The iodothyronine selenodeiodinases are thioredoxin-fold family proteins containing a glycoside hydrolase clan GH-A-like structure, J Biol Chem, 278, 36887, 10.1074/jbc.M305725200 · DOI · Paper page
  14. Canani, 2005, The type 2 deiodinase A/G (Thr92Ala) polymorphism is associated with decreased enzyme velocity and increased insulin resistance in patients with type 2 diabetes mellitus, J Clin Endocrinol Metab, 90, 3472, 10.1210/jc.2004-1977 · DOI · Paper page
  15. Capelo, 2008, Deiodinase-mediated thyroid hormone inactivation minimizes thyroid hormone signaling in the early development of fetal skeleton, Bone, 43, 921, 10.1016/j.bone.2008.06.020 · DOI · Paper page
  16. Carvalho, 1991, Central role of brown adipose tissue thyroxine 5′-deiodinase on thyroid hormone-dependent thermogenic response to cold, Endocrinology, 128, 2149, 10.1210/endo-128-4-2149 · DOI · Paper page
  17. Castillo, 2011, Disruption of thyroid hormone activation in type 2 deiodinase knockout mice causes obesity with glucose intolerance and liver steatosis only at thermoneutrality, Diabetes, 10.2337/db10-0758 · DOI · Paper page
  18. Chen, 2006, Increased WSB1 copy number correlates with its over-expression which associates with increased survival in neuroblastoma, Genes Chromosomes Cancer, 45, 856, 10.1002/gcc.20349 · DOI
  19. Chiamolera, 2009, Minireview: thyrotropin-releasing hormone and the thyroid hormone feedback mechanism, Endocrinology, 150, 1091, 10.1210/en.2008-1795 · DOI · Paper page
  20. Choi, 2008, Ubiquitination and degradation of homeodomain-interacting protein kinase 2 by WD40 repeat/SOCS box protein WSB-1, J Biol Chem, 283, 4682, 10.1074/jbc.M708873200 · DOI · Paper page
  21. Cook, 1997, Crystal structure of a class I ubiquitin conjugating enzyme (Ubc7) from Saccharomyces cerevisiae at 2.9Angstroms resolution, Biochemistry, 36, 1621, 10.1021/bi962639e · DOI
  22. Curcio-Morelli, 2003, In vivo dimerization of types 1, 2, and 3 iodothyronine selenodeiodinases, Endocrinology, 144, 937, 10.1210/en.2002-220960 · DOI · Paper page
  23. Curcio-Morelli, 2003, Deubiquitination of type 2 iodothyronine deiodinase by von Hippel–Lindau protein-interacting deubiquitinating enzymes regulates thyroid hormone activation, J Clin Invest, 112, 189, 10.1172/JCI18348 · DOI · Paper page
  24. da-Silva, 2007, The small polyphenolic molecule kaempferol increases cellular energy expenditure and thyroid hormone activation, Diabetes, 56, 767, 10.2337/db06-1488 · DOI · Paper page
  25. da-Silva, 2011, The chemical chaperones tauroursodeoxycholic and 4-phenylbutyric acid accelerate thyroid hormone activation and energy expenditure, FEBS Lett, 585, 539, 10.1016/j.febslet.2010.12.044 · DOI · Paper page
  26. de Jesus, 2001, The type 2 iodothyronine deiodinase is essential for adaptive thermogenesis in brown adipose tissue, J Clin Invest, 108, 1379, 10.1172/JCI200113803 · DOI · Paper page
  27. Dentice, 2010, The FoxO3/type 2 deiodinase pathway is required for normal mouse myogenesis and muscle regeneration, J Clin Invest, 120, 4021, 10.1172/JCI43670 · DOI · Paper page
  28. Dohán, 2003, The sodium/iodide symporter (NIS): characterization, regulation, and medical significance, Endocr Rev, 24, 48, 10.1210/er.2001-0029 · DOI · Paper page
  29. Engin, 2010, Restoring endoplasmic reticulum function by chemical chaperones: an emerging therapeutic approach for metabolic diseases, Diabetes Obes Metab, 12, 108, 10.1111/j.1463-1326.2010.01282.x · DOI · Paper page
  30. Friesema, 2006, Thyroid hormone transport by the human monocarboxylate transporter 8 and its rate-limiting role in intracellular metabolism, Mol Endocrinol, 20, 2761, 10.1210/me.2005-0256 · DOI · Paper page
  31. Galton, 1992, The role of thyroid hormone in amphibian metamorphosis, Trends Endocrinol Metab, 3, 96, 10.1016/1043-2760(92)90020-2 · DOI
  32. Galton, 2005, The roles of the iodothyronine deiodinases in mammalian development, Thyroid, 15, 823, 10.1089/thy.2005.15.823 · DOI · Paper page
  33. Gouveia, 2005, Type 2 iodothyronine selenodeiodinase is expressed throughout the mouse skeleton and in the MC3T3-E1 mouse osteoblastic cell line during differentiation, Endocrinology, 146, 195, 10.1210/en.2004-1043 · DOI · Paper page
  34. Grozovsky, 2009, Type 2 deiodinase expression is induced by peroxisomal proliferator-activated receptor-gamma agonists in skeletal myocytes, Endocrinology, 150, 1976, 10.1210/en.2008-0938 · DOI · Paper page
  35. Hall, 2010, Absence of thyroid hormone activation during development underlies a permanent defect in adaptive thermogenesis, Endocrinology, 151, 4573, 10.1210/en.2010-0511 · DOI · Paper page
  36. Hardt, 2002, Lysine can be replaced by histidine but not by arginine as the ER retrieval motif for type I membrane proteins, Biochem Biophys Res Commun, 291, 751, 10.1006/bbrc.2002.6515 · DOI
  37. Harhaj, 2011, Deubiquitinases in the regulation of NF-κB signaling, Cell Res, 21, 22, 10.1038/cr.2010.166 · DOI · Paper page
  38. Hassink, 2005, TEB4 is a C4HC3 RING finger-containing ubiquitin ligase of the endoplasmic reticulum, Biochem J, 388, 647, 10.1042/BJ20041241 · DOI · Paper page
  39. Heemstra, 2010, The type 2 deiodinase Thr92Ala polymorphism is associated with increased bone turnover and decreased femoral neck bone mineral density, J Bone Miner Res, 25, 1385, 10.1002/jbmr.27 · DOI · Paper page
  40. Hernandez, 2006, Type 3 deiodinase is critical for the maturation and function of the thyroid axis, J Clin Invest, 116, 476, 10.1172/JCI26240 · DOI · Paper page
  41. Houten, 2006, Endocrine functions of bile acids, EMBO J, 25, 1419, 10.1038/sj.emboj.7601049 · DOI · Paper page
  42. Hsieh, 2010, Differential regulation of proliferation, cell cycle control and gene expression in cultured human aortic and pulmonary artery endothelial cells by resveratrol, Int J Mol Med, 26, 743
  43. Imai, 2001, An unfolded putative transmembrane polypeptide, which can lead to endoplasmic reticulum stress, is a substrate of Parkin, Cell, 105, 891, 10.1016/S0092-8674(01)00407-X · DOI · Paper page
  44. Kim, 2003, Endoplasmic reticulum-associated degradation of the human type 2 iodothyronine deiodinase (D2) is mediated via an association between mammalian UBC7 and the carboxyl region of D2, Mol Endocrinol, 17, 2603, 10.1210/me.2003-0082 · DOI · Paper page
  45. Komander, 2010, Mechanism, specificity and structure of the deubiquitinases, Subcell Biochem, 54, 69, 10.1007/978-1-4419-6676-6_6 · DOI
  46. Komander, 2009, Breaking the chains: structure and function of the deubiquitinases, Nat Rev Mol Cell Biol, 10, 550, 10.1038/nrm2731 · DOI · Paper page
  47. Kreft, 2006, Membrane topology of the yeast endoplasmic reticulum-localized ubiquitin ligase Doa10 and comparison with its human ortholog TEB4 (MARCH-VI), J Biol Chem, 281, 4646, 10.1074/jbc.M512215200 · DOI · Paper page
  48. Leonard, 1990, Regulation of type II iodothyronine 5′-deiodinase by thyroid hormone. Inhibition of actin polymerization blocks enzyme inactivation in cAMP-stimulated glial cells, J Biol Chem, 265, 940, 10.1016/S0021-9258(19)40140-3 · DOI · Paper page
  49. Leonard, 2001, Characterization of the subunit structure of the catalytically active type I iodothyronine deiodinase, J Biol Chem, 276, 2600, 10.1074/jbc.M006973200 · DOI · Paper page
  50. Li, 2002, Ubiquitination of a novel deubiquitinating enzyme requires direct binding to von Hippel–Lindau tumor suppressor protein, J Biol Chem, 277, 4656, 10.1074/jbc.M108269200 · DOI · Paper page
  51. Li, 2005, VHL protein-interacting deubiquitinating enzyme 2 deubiquitinates and stabilizes HIF-1alpha, EMBO Rep, 6, 373, 10.1038/sj.embor.7400377 · DOI · Paper page
  52. Li, 2002, Identification of a deubiquitinating enzyme subfamily as substrates of the von Hippel–Lindau tumor suppressor, Biochem Biophys Res Commun, 294, 700, 10.1016/S0006-291X(02)00534-X · DOI
  53. Ling, 2006, CTCF mediates interchromosomal colocalization between Igf2/H19 and Wsb1/Nf1, Science, 312, 269, 10.1126/science.1123191 · DOI · Paper page
  54. Liu, 2010, Ubiquitin chain elongation enzyme Ufd2 regulates a subset of Doa10 substrates, J Biol Chem, 285, 10265, 10.1074/jbc.M110.110551 · DOI
  55. Lu, 2009, Retarded developmental expression and patterning of retinal cone opsins in hypothyroid mice, Endocrinology, 150, 1536, 10.1210/en.2008-1092 · DOI
  56. Meusser, 2005, ERAD: the long road to destruction, Nat Cell Biol, 7, 766, 10.1038/ncb0805-766 · DOI · Paper page
  57. Miura, 2002, Thyroid hormones promote chondrocyte differentiation in mouse ATDC5 cells and stimulate endochondral ossification in fetal mouse tibias through iodothyronine deiodinases in the growth plate, J Bone Miner Res, 17, 443, 10.1359/jbmr.2002.17.3.443 · DOI · Paper page
  58. Ng, 2004, Hearing loss and retarded cochlear development in mice lacking type 2 iodothyronine deiodinase, Proc Natl Acad Sci U S A, 101, 3474, 10.1073/pnas.0307402101 · DOI · Paper page
  59. Ng, 2010, Type 3 deiodinase, a thyroid-hormone-inactivating enzyme, controls survival and maturation of cone photoreceptors, J Neurosci, 30, 3347, 10.1523/JNEUROSCI.5267-09.2010 · DOI · Paper page
  60. Ozcan, 2009, Endoplasmic reticulum stress plays a central role in development of leptin resistance, Cell Metab, 9, 35, 10.1016/j.cmet.2008.12.004 · DOI · Paper page
  61. Ozcan, 2008, Loss of the tuberous sclerosis complex tumor suppressors triggers the unfolded protein response to regulate insulin signaling and apoptosis, Mol Cell, 29, 541, 10.1016/j.molcel.2007.12.023 · DOI · Paper page
  62. Ozcan, 2006, Chemical chaperones reduce ER stress and restore glucose homeostasis in a mouse model of type 2 diabetes, Science, 313, 1137, 10.1126/science.1128294 · DOI · Paper page
  63. Park, 2010, Sarco(endo)plasmic reticulum Ca2+-ATPase 2b is a major regulator of endoplasmic reticulum stress and glucose homeostasis in obesity, Proc Natl Acad Sci U S A, 107, 19320, 10.1073/pnas.1012044107 · DOI · Paper page
  64. Ramakrishna, 2011, The role of deubiquitinating enzymes in apoptosis, Cell Mol Life Sci, 68, 15, 10.1007/s00018-010-0504-6 · DOI
  65. Ravid, 2006, Membrane and soluble substrates of the Doa10 ubiquitin ligase are degraded by distinct pathways, EMBO J, 25, 533, 10.1038/sj.emboj.7600946 · DOI · Paper page
  66. Safran, 1991, Comparison of the physicochemical properties of type I and type II iodothyronine 5′-deiodinase, J Biol Chem, 266, 3233, 10.1016/S0021-9258(18)49979-6 · DOI · Paper page
  67. Sagar, 2008, The thyroid hormone-inactivating deiodinase functions as a homodimer, Mol Endocrinol, 22, 1382, 10.1210/me.2007-0490 · DOI · Paper page
  68. Salvatore, 1995, Type 3 lodothyronine deiodinase: cloning, in vitro expression, and functional analysis of the placental selenoenzyme, J Clin Invest, 96, 2421, 10.1172/JCI118299 · DOI · Paper page
  69. Schneider, 2001, Targeted disruption of the type 2 selenodeiodinase gene (DIO2) results in a phenotype of pituitary resistance to T4, Mol Endocrinol, 15, 2137, 10.1210/mend.15.12.0740 · DOI · Paper page
  70. Schröder, 2008, Endoplasmic reticulum stress responses, Cell Mol Life Sci, 65, 862, 10.1007/s00018-007-7383-5 · DOI · Paper page
  71. Schröder, 2010, Consequences of stress in the secretory pathway: the ER stress response and its role in the metabolic syndrome, Methods Mol Biol, 648, 43, 10.1007/978-1-60761-756-3_3 · DOI
  72. Silva, 2011, Physiological importance and control of non-shivering facultative thermogenesis, Front Biosci (Schol Ed), 3, 352, 10.2741/s156 · DOI · Paper page
  73. Spang, 2009, On vesicle formation and tethering in the ER–Golgi shuttle, Curr Opin Cell Biol, 21, 531, 10.1016/j.ceb.2009.03.003 · DOI
  74. St Germain, 2009, Minireview: defining the roles of the iodothyronine deiodinases: current concepts and challenges, Endocrinology, 150, 1097, 10.1210/en.2008-1588 · DOI · Paper page
  75. St Germain, 2005, Insights into the role of deiodinases from studies of genetically modified animals, Thyroid, 15, 905, 10.1089/thy.2005.15.905 · DOI · Paper page
  76. Steinsapir, 2000, Substrate-induced down-regulation of human type 2 deiodinase (hD2) is mediated through proteasomal degradation and requires interaction with the enzyme's active center, Endocrinology, 141, 1127, 10.1210/endo.141.3.7355 · DOI · Paper page
  77. Swanson, 2001, A conserved ubiquitin ligase of the nuclear envelope/endoplasmic reticulum that functions in both ER-associated and Matalpha2 repressor degradation, Genes Dev, 15, 2660, 10.1101/gad.933301 · DOI · Paper page
  78. Tiwari, 2001, Endoplasmic reticulum (ER)-associated degradation of T cell receptor subunits. Involvement of ER-associated ubiquitin-conjugating enzymes (E2s), J Biol Chem, 276, 16193, 10.1074/jbc.M007640200 · DOI · Paper page
  79. Trimarchi, 2008, Thyroid hormone components are expressed in three sequential waves during development of the chick retina, BMC Dev Biol, 8, 101, 10.1186/1471-213X-8-101 · DOI
  80. Vasiliauskas, 1999, SWiP-1: novel SOCS box containing WD-protein regulated by signalling centres and by Shh during development, Mech Dev, 82, 79, 10.1016/S0925-4773(99)00014-3 · DOI · Paper page
  81. Xiao, 2011, Sodium phenylbutyrate, a drug with known capacity to reduce endoplasmic reticulum stress, partially alleviates lipid-induced insulin resistance and {beta}-cell dysfunction in humans, Diabetes, 60, 918, 10.2337/db10-1433 · DOI · Paper page
  82. Yang, 2010, Eaten alive: a history of macroautophagy, Nat Cell Biol, 12, 814, 10.1038/ncb0910-814 · DOI · Paper page
  83. Yuasa-Kawada, 2009, Deubiquitinating enzyme USP33/VDU1 is required for Slit signaling in inhibiting breast cancer cell migration, Proc Natl Acad Sci U S A, 106, 14530, 10.1073/pnas.0801262106 · DOI
  84. Zavacki, 2009, The E3 ubiquitin ligase TEB4 mediates degradation of type 2 iodothyronine deiodinase, Mol Cell Biol, 29, 5339, 10.1128/MCB.01498-08 · DOI · Paper page
  85. Zeöld, 2006, Metabolic instability of type 2 deiodinase is transferable to stable proteins independently of subcellular localization, J Biol Chem, 281, 31538, 10.1016/S0021-9258(19)84067-X · doi:10.1016/s0021-9258(19)84067-x

Cited by

Metadata

Authors
Arrojo e Drigo, R., & Bianco, A. C.
Venue
The International Journal of Biochemistry & Cell Biology
Publisher
Elsevier BV
Published
2011-10
Volume
43
Issue
10
Pages
1432-1441
ISSN
1357-2725 (ISSN-L)
OpenAlex
W2111273535
Cited by
93
References
28
FWCI
4.24
Type
journal article
Language
en
Open access
green
Licence
  • www.elsevier.com/tdm/userlicense/1.0/ (tdm)
  • www.elsevier.com/legal/tdmrep-license (tdm)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.